The latest news and updates from CERA – from new research advances, to awards and funding, to stories of the real-life impact of our research.
Australia’s first investigational gene therapy trials for dry age-related macular degeneration under way
Australia’s first clinical trials of an investigational gene therapy to treat dry age-related macular degeneration (AMD) have begun at the Centre for Eye Research Australia (CERA).
Scientists have used a new gene therapy technique to repair damage to nerve cell transport systems that cause vision loss in glaucoma and memory loss in dementia.
Watch Professor Keith Martin, Associate Professor Lyndell Lim and PolyActiva’s Dr Russell Tait discuss how eye research clinical trials contribute to the health and wealth of our community.